data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRDgwMDI3IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHoiLz48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCAzMTIuODgyaDUxMnYxMTMuNzc1SDB6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+

data:image/svg+xml;base64,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

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+

data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Yield
How to Buy Corporate Bonds
How to Buy Treasury Bonds
How to Invest in Real Estate Online
Money
Compare Online Brokers
Stock Brokers
Forex Brokers
Futures Brokers
Crypto Brokers
Options Brokers
ETF Brokers
Mutual Fund Brokers
Index Fund Brokers
Bond Brokers
Short Selling Brokers
Stock Apps
All Broker Reviews
Insurance
Auto
Home
Medicare
Life
Vision
Dental
Business
Pet
Health
Motorcycle
Renters
Workers Comp
Top Stocks
Penny Stocks
Stocks Under $5
Stocks Under $10
Stocks Under $20
Stocks Under $50
Stocks Under $100
Alternative Investing
Invest in Art
Invest in Watches
Invest in Land
Invest in Real Estate
Invest in Wine
Invest in Gold
Mortgages
Refinance
Purchase
Find a Mortgage Broker
Alts
Alternative Investment Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
How to Invest in Jewelry
Best Real Estate Crowdfunding Platforms
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Get Started
Is Bitcoin a Good Investment?
Is Ethereum a Good Investment?
What is Blockchain
Best Altcoins
How to Buy Cryptocurrency?
DeFi
Crypto and DeFi 101
What is DeFi?
Decentralized Exchanges
Best DeFi Yield Farms
Digital Securities
NFTs
NFT Release Calendar
What is a Non-Fungible Token (NFT)?
How to Buy Non-Fungible Tokens (NFTs)
CryptoPunks Watchlist
Are NFTs a Scam or a Digital Bubble?
Best In Crypto
Best Crypto Apps
Best Crypto Portfolio Trackers
Best Crypto Day Trading Strategies
Best Crypto IRA
Best Cryptocurrency Scanners
Best Business Crypto Accounts
Best Crypto Screeners
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Hims & Hers Health Inc

(NYSE:HIMS)

Perks Buy Compare Brokers

$8.6399

-0.0801[-0.92%]

Last update: 7:06PM (Delayed 15-Minutes)
Get Real Time Here

$8.6399

0[0.00%]

After-Hours

Perks Buy Compare Brokers

Open8.670	Close8.640
Vol / Avg.1.907M / 2.532M	Mkt Cap1.832B
Day Range8.595 - 8.770	52 Wk Range5.650 - 12.340

0

Latest News for Hims & Hers Health Stock (NYSE:HIMS)

Hims & Hers Health Stock (NYSE: HIMS)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, December 04, 2023

Hims & Hers Launches Holistic Weight Loss Program To Break The Endless Cycle Of Weight Gain And Loss
Benzinga Newsdesk - 4 days ago

Friday, November 17, 2023

Top 5 Health Care Stocks That May Collapse In November
Lisa Levin - Nov 17, 2023, 8:33AM

Thursday, November 09, 2023

Himax Technologies Sees Q4 Revenues To Decline 5.0% - 11.0% Sequentially
Benzinga Newsdesk - Nov 9, 2023, 5:26AM

Tuesday, November 07, 2023

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Nov 7, 2023, 1:10PM
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
Lisa Levin - Nov 7, 2023, 10:54AM
Hims & Hers shares are trading higher after the company reported better-than-expected Q3 sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
Benzinga Newsdesk - Nov 7, 2023, 9:31AM

Monday, November 06, 2023

MSP Recovery, Uber, Hims & Hers Health, Celsius, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Benzinga Neuro - Nov 6, 2023, 9:26PM
Hims & Hers Health Q3 Results Mixed But FY23 Revenue Guidance Raised, $50 Million Share Buyback
Ryan Gustafson - Nov 6, 2023, 4:50PM
Hims & Hers shares are trading higher after the company reported better-than-expected Q3 sales results, raised FY23 guidance above estimates and announced a $50 million share repurchase program.
Benzinga Newsdesk - Nov 6, 2023, 4:48PM
Hims & Hers Health Q3 2023 Gaap EPS $(0.04) Misses $(0.03) Estimate, Sales $226.70M Beat $220.05M Estimate
Benzinga Newsdesk - Nov 6, 2023, 4:23PM
Hims & Hers Health Raises 2023 Revenue Guidance To $868M-$873M vs $846.55M Est.
Benzinga Newsdesk - Nov 6, 2023, 4:09PM
Hims & Hers Health Q3 Revenue $226.7M vs $220.048M Est.
Benzinga Newsdesk - Nov 6, 2023, 4:07PM
Hims & Hers Health Raises Full Year 2023 Outlook
Benzinga Newsdesk - Nov 6, 2023, 4:06PM
Hims & Hers Health, Inc. Announces $50M Share Repurchase Program Authorization
Benzinga Newsdesk - Nov 6, 2023, 4:06PM
Earnings Scheduled For November 6, 2023
Benzinga Insights - Nov 6, 2023, 8:24AM

Monday, October 23, 2023

"Viagra Could Slash Risk Of Alzheimer's Disease By 60%: Study" - NY Post
Benzinga Newsdesk - Oct 23, 2023, 10:17AM

Monday, October 09, 2023

10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights - Oct 9, 2023, 1:35PM

Thursday, October 05, 2023

Hims & Hers Health Chief Operating Officer Trades Company's Stock
Benzinga Insights - Oct 5, 2023, 11:02AM

Wednesday, August 09, 2023

Truist Securities Maintains Hold on Hims & Hers Health, Lowers Price Target to $10
Benzinga Newsdesk - Aug 9, 2023, 10:11AM

Tuesday, August 08, 2023

Hims & Hers Health Reports Q2 Earnings, Beating Top And Bottom Lines, Raises Guidance
Ryan Gustafson - Aug 8, 2023, 3:28PM
Hims & Hers Health shares are trading lower as the stock pulls back after gaining on strong earnings and guidance.
Benzinga Newsdesk - Aug 8, 2023, 3:05PM
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Aug 8, 2023, 1:13PM
Fox, Warner Music, Eli Lilly, Chegg And Other Big Stocks Moving Higher On Tuesday
Lisa Levin - Aug 8, 2023, 10:35AM
Hims & Hers Health shares are trading higher after the company reported better-than-expected Q2 financial results and raised FY23 revenue guidance.
Benzinga Newsdesk - Aug 8, 2023, 9:34AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Aug 8, 2023, 9:06AM
Why Hims & Hers Health Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Aug 8, 2023, 8:20AM
Credit Suisse Reiterates Outperform on Hims & Hers Health, Maintains $14 Price Target
Benzinga Newsdesk - Aug 8, 2023, 8:12AM

Monday, August 07, 2023

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - Aug 7, 2023, 5:32PM
Hims & Hers Health Expects Q3 Revenue Of $217M-$222M, Consensus $213.78M
Benzinga Newsdesk - Aug 7, 2023, 5:16PM
Hims & Hers Health Raises Full Year 2023 Revenue Guidance From $810M-$830M To $830M-$850M; Consensus $830.75M
Benzinga Newsdesk - Aug 7, 2023, 5:14PM
Hims & Hers Health Q2 EPS $(0.03) Beats $(0.06) Estimate, Sales $207.91M Beat $204.62M Estimate
Benzinga Newsdesk - Aug 7, 2023, 4:35PM
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights - Aug 7, 2023, 1:35PM
Earnings Scheduled For August 7, 2023
Benzinga Insights - Aug 7, 2023, 4:12AM

Friday, August 04, 2023

Earnings Outlook For Hims & Hers Health
Benzinga Insights - Aug 4, 2023, 10:01AM

Friday, July 28, 2023

Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Benzinga Insights - Jul 28, 2023, 11:00AM
TD Cowen Initiates Coverage On Hims & Hers Health with Outperform Rating, Announces Price Target of $11
Benzinga Newsdesk - Jul 28, 2023, 8:39AM

Thursday, July 27, 2023

Ryan Reynolds Is Bringing A Popular Television Alien Back To Screens, Hide Your Cats!
Chris Katje - Jul 27, 2023, 3:54PM

Thursday, July 13, 2023

Hims & Hers Hit With Short Seller Wrecking Ball: Spruce Point Cites 'No Cost Advantage', Legal Concerns
Chris Katje - Jul 13, 2023, 4:13PM
Spruce Point Capital Says Spruce Point Has A Short Position In Hims & Hers Health, Inc.; Identifies Serious Operational Risks Related To Several Third-Party Pharmacy Partners; Believe Shares Of Hims & Hers Health, Face Up To 25% To 40% Long-Term Downside Risk To $5.20-$6.50 Per Share
Happy Mohamed - Jul 13, 2023, 9:03AM
Spruce Point Capital Management Announces Investment Opinion: Releases Report And Strong Sell Research Opinion On Hims & Hers Health, Inc.
Happy Mohamed - Jul 13, 2023, 9:02AM
Viasat, MillerKnoll And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Lisa Levin - Jul 13, 2023, 6:33AM

Thursday, June 15, 2023

Analyst Ratings for Hims & Hers Health
Benzinga Insights - Jun 15, 2023, 3:01PM
Tigress Financial Reiterates Buy on Hims & Hers Health, Raises Price Target to $14
Benzinga Newsdesk - Jun 15, 2023, 11:40AM

Tuesday, May 30, 2023

6 Analysts Have This to Say About Hims & Hers Health
Benzinga Insights - May 30, 2023, 2:01PM
Analyst Expectations for Hims & Hers Health's Future
Benzinga Insights - May 30, 2023, 8:07AM
Piper Sandler Maintains Neutral on Hims & Hers Health, Lowers Price Target to $11
Benzinga Newsdesk - May 30, 2023, 7:22AM

Tuesday, May 09, 2023

B of A Securities Maintains Buy on Hims & Hers Health, Raises Price Target to $15
Benzinga Newsdesk - May 9, 2023, 10:46AM
Piper Sandler Maintains Neutral on Hims & Hers Health, Raises Price Target to $12
Benzinga Newsdesk - May 9, 2023, 9:29AM
Hims & Hers Health shares are trading lower despite the company reporting better-than-expected Q1 financial results and raising guidance.
Benzinga Newsdesk - May 9, 2023, 8:31AM

Monday, May 08, 2023

Hims & Hers Health Sees FY23 Revenue $810M-$830M Vs $755.28M Est
Benzinga Newsdesk - May 8, 2023, 4:18PM

1
2
3
4
5
6
7
Next
17

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2023 Benzinga | All Rights Reserved